Bank of Montreal’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,003
Closed -$12K 3979
2023
Q2
$12K Sell
8,003
-2,590
-24% -$3.23K ﹤0.01% 3789
2023
Q1
$13.5K Buy
+10,593
New +$20.3K ﹤0.01% 3584
2021
Q2
Sell
-2,168
Closed -$20K 4176
2021
Q1
$20K Sell
2,168
-7,023
-76% -$70.8K ﹤0.01% 4062
2020
Q4
$99K Buy
9,191
+6,151
+202% +$60.6K ﹤0.01% 3590
2020
Q3
$38K Sell
3,040
-1,337
-31% -$17.7K ﹤0.01% 3552
2020
Q2
$57K Buy
4,377
+3,967
+968% +$49.9K ﹤0.01% 3382
2020
Q1
$4K Sell
410
-5,552
-93% -$72.5K ﹤0.01% 3717
2019
Q4
$93K Buy
5,962
+1,341
+29% +$27K ﹤0.01% 3532
2019
Q3
$78K Buy
4,621
+1,782
+63% +$35.4K ﹤0.01% 3411
2019
Q2
$63K Buy
2,839
+1,679
+145% +$32.1K ﹤0.01% 3578
2019
Q1
$25K Buy
+1,160
New +$24.2K ﹤0.01% 3588

Other funds holding GOSS

Bank of Montreal's GOSS Position: Q3 2023 in Review

Bank of Montreal sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 8,003 shares — an estimated $12K sold.

Bank of Montreal first reported a position in GOSS in Q1 2019 and held it in 11 quarters. The position peaked at $99K in Q4 2020. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Bank of Montreal reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 8,003 Gossamer Bio shares in Q3 2023, an estimated $12K.
  • Bank of Montreal first reported a position in Gossamer Bio in Q1 2019 and held it in 11 quarters.
  • Bank of Montreal's Gossamer Bio position peaked at $99K in Q4 2020.
  • 95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.